Miyamoto, T., Komuro, M., Aihara, R., Ohira, C., Kaneki, M., Iwashita, N., . . . Fukuyama, T. Short-Term Oral Administration of 1.5 μg/kg bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. MDPI AG.
Chicago Style (17th ed.) CitationMiyamoto, Takayoshi, et al. Short-Term Oral Administration of 1.5 μg/kg Bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. MDPI AG.
MLA (9th ed.) CitationMiyamoto, Takayoshi, et al. Short-Term Oral Administration of 1.5 μg/kg Bw/day of Deoxynivalenol Significantly Exacerbates Inflammatory and Itching Symptoms in a Mouse Model of Imiquimod-Induced Psoriasis. MDPI AG.
Warning: These citations may not always be 100% accurate.